No new device-related treatment-emergent adverse events (TEAEs) were observed between six and 12 months
Key takeaways Digestive enzymes are non-living proteins that break down food into nutrients the body can absorb and use
Most GLP-1 side effects are gastrointestinal, mild, and improve within the first few weeks of each dose level Serious warning signs severe abdominal pain, persistent vomiting, or allergic reactions are rare but require immediate medical attention Wegovy, Zepbound, and Foundayo share a similar GI side-effect profile, with some differences in nausea and diarrhea frequency In-person monitoring at PEAK allows your clinician to catch issues early and adjust your titration schedule in real time Starting a GLP-1 medication like Wegovy (semaglutide), Zepbound (tirzepatide), or Foundayo (orforglipron) is a major step toward better health and it is completely normal to wonder what to expect along the way
Lilly Introduces Single-Dose Vials of Zepbound, Expanding Access for Adults with Obesity
If eating becomes impossible rather than simply reduced, the dose is likely too high